Flu vaccines for over-65s to be delivered on time, supplier says


Facebook
Twitter
LinkedIn

By Beth Gault

12 Sep 2019

The batch of new season of flu vaccines for the over-65s are due to be delivered on time despite manufacturing challenges, according to vaccine supplier Seqirus.

The supplier, which manufactures the adjuvanted trivalent vaccine (aTIV) Fluad which is used for over-65s, said community pharmacies will receive all deliveries of the a-TIV vaccines before a potential no-deal Brexit on 31 October.

It said deliveries are already underway and ‘agreed’ delivery times would be met, despite a delay in the World Health Organisation’s (WHO) strain announcement.

It follows reports that some flu vaccines would be delayed until November this year after delays to the WHO recommendation on flu vaccines, after it took more time to adjust to the key strains in circulation.

Last year pharmacies were told they would receive their stock of aTIV in a phased manner over three months – with 40% delivered in September, 20% in October and 40% in November.

Due to the delay, a temporary relaxation in regulations was put in place to enable GP practices and pharmacies to swap flu vaccine stocks.

UK country head at Seqirus Helen Concilia said: ‘The swift change over to aTIV for the entire 65 plus population across the UK last season was a complex operation for all of us working on the front line of influenza prevention.

‘However, the hard work from GPs, practice nurses and practice managers was effort well placed as aTIV appears to have significantly reduced the risk of influenza and medical visits in older adults in 2018-19, as highlighted by recent Public Health England data.’


Want news like this straight to your inbox?


Latest News

How to make sure you get paid for the Pharmacy Quality Scheme
With NHS data showing that a third of community pharmacies have yet to meet key...
Vaping still safer than smoking, health officials reiterate amidst fresh concerns
Public health officials have reiterated that regulated e-cigarettes carry a 'fraction' of the risk of...
Cost of medicines prescribed in primary care falls by almost £250m since last year, figures reveal
The cost of medicines in England prescribed in primary care has fallen by almost £250m...